Malignant pleural mesothelioma is a devastating
cancer, with survival rates ranging from as low as 17% to 46%. Diagnosis and/or treatment usually involves an invasive chest wall procedure, however, this carries the risk of tumor-
cell seeding at the site of the procedure and subsequent development of metastases. Due to this risk, prophylactic radiotherapy is commonly […]